Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05504070 · ClinicalTrials.gov registry record · NA

Venclose digiRF System Post Market Study

A NA study of Chronic Venous Insufficiency and Venous Reflux, sponsored by C. R. Bard.

Active
Registry status
NA
Development phase
203
Enrollment target
7
Study locations

NCT05504070 is a NA study of Chronic Venous Insufficiency and Venous Reflux that is active but no longer recruiting, run by C. R. Bard. The registered enrollment target is 203 participants, above the 109-participant average among 3 other Chronic Venous Insufficiency trials with a reported enrollment target (86% higher). The trial reports 7 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05504070, a NA study of Chronic Venous Insufficiency and Venous Reflux, is active but no longer recruiting, sponsored by C. R. Bard.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
203 participants
Enrollment target
7
Study locations

Study Summary

A Post-Market, Multi-Center, Prospective, Interventional Study for Treatment of Chronic Venous Disease of the Great and Small Saphenous Veins and Incompetent Perforator Veins.

Interventions

  • DEVICE Venclose System (digiRF generator w EVSRF catheter)
  • DEVICE Venclose MAVEN System (digiRF generator w MAVEN catheter)

Study Locations (7)

Colorado

  • ClinRe - Thornton

Hawaii

  • Pacific Vascular Institute - Kailua

Michigan

  • Eastlake Cardiovascular - Roseville

New Jersey

  • Englewood Hospital - Englewood

North Carolina

  • Atrium Health - Charlotte

Texas

  • Christus Health - Tyler

Virginia

  • ClinRe - Colonial Heights

Trial Details

FieldValue
Enrollment Target 203 participants
Start Date 2023-09-08
Est. Completion 2027-06
Phase NA

Sponsor

C. R. Bard

75 total trials

What the Registry Record Tells You About NCT05504070

The ClinicalTrials.gov registry entry for NCT05504070 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 203 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 109-participant average among 3 other Chronic Venous Insufficiency trials with a reported enrollment target (86% higher). The listed sponsor is C. R. Bard, which has 75 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Chronic Venous Insufficiency appearing as the primary indexed condition, and to 2 interventions - of which Venclose System (digiRF generator w EVSRF catheter) is the first listed.

NCT05504070 reports 7 study locations spanning 7 distinct geographic areas - top geographies include Colorado, Hawaii, Michigan.

Frequently Asked Questions

What is clinical trial NCT05504070 about?

NCT05504070 is a clinical study titled "Venclose digiRF System Post Market Study". A Post-Market, Multi-Center, Prospective, Interventional Study for Treatment of Chronic Venous Disease of the Great and Small Saphenous Veins and Incompetent Perforator Veins.

What is the current status of trial NCT05504070?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 203 participants. The study started on 2023-09-08. Estimated completion is 2027-06.

What conditions does trial NCT05504070 study?

This clinical trial studies the following conditions: Chronic Venous Insufficiency, Venous Reflux.

What interventions are being tested in trial NCT05504070?

The interventions under investigation include: Venclose System (digiRF generator w EVSRF catheter) (DEVICE), Venclose MAVEN System (digiRF generator w MAVEN catheter) (DEVICE).

Who is sponsoring clinical trial NCT05504070?

This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05504070 being conducted?

This trial has 7 study locations across Colorado, Hawaii, Michigan, New Jersey, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Venous Insufficiency

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.